Critical pathway for deceased donors: An analysis in three regions of Colombia



Palabras clave:

tissue and organ procurement, tissue donors, donor selection, organ preservation, organ transplantation


Introduction. The critical pathway for deceased donation offers a methodical framework for guiding the donation process. It not only serves to assess performance but also to identify areas of potential improvement. Therefore, the identification and selection of potential organ donors (POD) is a key process. This study aims to describe the critical pathway for deceased donation in a cohort of POD in three regions (CRT1, CRT2, and CRT5) of Colombia.

Methods. We retrospectively reviewed data of POD assessed from January 2022 to December 2022. General characteristics of POD, diagnosis, contraindication causes, and organ procurement were described. Analysis was conducted using the Chi-squared test for categorical variables and the Mann-Whitney test for quantitative variables.

Results. Within the cohort of 1451 assessed POD, 441 (30.3%) were diagnosed with brain death. Among potential donors after brain death, 198 (44.9%) were eligible donors (medically suitable). Of these, 157 donors (79.3%) became actual donors (undergoing operative incision for organ recovery), with 147 (96.3%) having at least one organ recovered (actual donors with organ recovery). Ultimately, 411 utilized organs were utilized. Additionally, there were observed differences in the characteristics of donors from different regions.

Conclusion. This study reports the critical pathway for deceased donation in a cohort of POD in three regions of Colombia. This provides useful information and helps to gain insight and understanding into the process of organ donation and organ procurement in order to take actions that could improve the donation rates.


Los datos de descargas todavía no están disponibles.

Biografía del autor/a

Milena Orellano-Salas, Fundonar Colombia, Bogotá, D.C., Colombia.

Transplants Coordination.

Luisa Fernanda Vargas, Fundonar Colombia, Bogotá, D.C., Colombia.

Transplants Coordination.

Ximena Escobar-Cháves, Fundonar Colombia, Bogotá, D.C., Colombia.

Transplants Coordination.

Andrea García-López, Colombiana de Trasplantes, Bogotá, D.C., Colombia.

Research Coordination.

Referencias bibliográficas

Park C, Jones MM, Kaplan S, Koller FL, Wilder JM, Boulware LE, et al. A scoping review of inequities in access to organ transplant in the United States. Int J Equity Heal. 2023;21:1-20.

Rodrigue JR, Cornell DL, Howard RJ. Organ donation decision: comparison of donor and nondonor families. Am J Transplant. 2006;6:190–8.

Domínguez-Gil B, Ascher NL, Fadhil RAS, Muller E, Cantarovich M, Ahn C, et al. The reality of inadequate patient care and the need for a global action framework in organ donation and transplantation. Transplantation. 2022;106:2111–7.

Stewart D, Hasz R, Lonze B. Beyond donation to organ utilization in the USA. Curr Opin Organ Transplant. 2023;28:197–206. 000000001060

Puri P, Kumar A, Qaleem M. Donor evaluation protocol for live and deceased donors. J Clin Exp Hepatol. 2024;14:101217

IRODaT - International Registry on Organ Donation and Transplantation. [cited 2023 Aug 31]. Available from:

Qu Z, Oedingen C, Bartling T, Beneke J, Zink M, Krauth C, et al. Systematic review on potential brain dead donor estimations and conversion rates to actually realized organ donations. Transplant Rev. 2021;35:100638.

Estupiñán-Bohórquez A, Acosta-Reyes J, Viasus-Pérez D, García-López A, Patino-Jaramillo N, Girón-Luque F. Trasplante renal de donantes con criterios expandidos en la región Caribe colombiana. Nefrol Latinoam. 2021;18:119-27.

(EDQM) ED for the Q of M& H. Guide to the quality and safety of organs for transplantation. 7th ed. European Directorate for the Quality of Medicines & Healthcare 2018. Available from:

Aristizábal AM, Castrillón Y, Gil T, Restrepo D, Guevara M, Solano K, et al. Manejo actual del donante potencial de órganos y tejidos en muerte cerebral: guía de manejo y revisión de la literatura. Rev Colomb Cir. 2023;32:128– 45.

Gotlieb N, Azhie A, Sharma D, Spann A, Suo NJ, Tran J, et al. The promise of machine learning applications in solid organ transplantation. NPJ Digit Med. 2022; 5(1):89.

Toews M, Chandler JA, Pope T, Pape R, Weiss M, Sandiumenge A. Legislation and policy recommendations on organ and tissue donation and transplantation from an international consensus forum. Transplant Direct. 2023;9:e1395.

Johnston-Webber C, Prionas A, Wharton G, Streit S, Mah J, Boletis I, et al. The national organ donation and transplantation program in Greece: Gap analysis and recommendations for change. Transpl Int. 2023; 36:11013.

Streit S, Johnston-Webber C, Mah J, Prionas A, Wharton G, Casanova D, et al. Ten lessons from the spanish model of organ donation and transplantation. Transpl Int. 2023;36:11009.

Schutter R, Vrijlandt WAL, Weima GM, Pol RA, Sanders JSF, Crop MJ, et al. Kidney utilization in the Netherlands – do we optimally use our donor organs? Nephrol Dial Transplant. 2023;38:787–96.

Al Moweshy AA, Fabella EL, Al-Hassan YT, Alramadan HA, Al Abdullah AJ, Al Hassan HI, et al. Association between organ donation awareness and willingness among Saudi university students. J Public Health Res. 2022;11:2685.

Vilayur E, van Zwieten A, Chen M, Francis A, Wyld M, Kim S, et al. Sex and gender disparities in living kidney donation: A scoping review. Transplant Direct. 2023;9:e1530.

Instituto Nacional de Salud, Ministerio de Salud y Protección Social. Informe ejecutivo Red de Donación y Trasplantes 2022. Bogotá DC, Colombia; 2022.

Torres-Gutiérrez M. La evaluación psicosocial de un donante vivo de riñón. Rev Colomb Psiquiatr. 2018;47:252–7.

Englbrecht JS, Schrader D, Kraus H, Schäfer M, Schedler D, Bach F, et al. How large is the potential of brain dead donors and what prevents utilization? A multicenter retrospective analysis at seven university hospitals in North Rhine-Westphalia. Transpl Int. 2023;36:11186.

Shah KK, Wyld M, Hedley JA, Waller KMJ, De La Mata N, Webster AC, et al. Cost-effectiveness of kidney transplantation from donors at increased risk of blood-borne virus infection transmission. Transplantation. 2023;107:2028-42. 0000004632

Grossi AA, Randhawa G, Jansen NE, Paredes-Zapata D. Taking a “care pathway/whole systems” approach to Equality Diversity Inclusion (EDI) in organ donation and transplantation in relation to the needs of “ethnic/ racial/migrant” minority communities: A statement and a call for action. Transpl Int. 2023;36:11310.



Cómo citar

Cruz-Mususú, W.; Orellano-Salas, M.; Vargas, L. F.; Escobar-Cháves, X.; García-López, A.; Lozano-Suárez, N.; Gómez-Montero, A.; Girón-Luque, F. Critical Pathway for Deceased Donors: An Analysis in Three Regions of Colombia. Rev Colomb Cir 2023, 39, 449-458.



Artículo Original


Crossref Cited-by logo
QR Code